63.46
1.42 (2.29%)
| Previous Close | 62.04 |
| Open | 62.37 |
| Volume | 230,973 |
| Avg. Volume (3M) | 51,342 |
| Market Cap | 202,612,480 |
| Price / Earnings (TTM) | 17.48 |
| Price / Earnings (Forward) | 22.27 |
| Price / Sales | 2.75 |
| Price / Book | 4.37 |
| 52 Weeks Range |
| Profit Margin | 14.61% |
| Operating Margin (TTM) | 20.90% |
| Diluted EPS (TTM) | 2.76 |
| Quarterly Revenue Growth (YOY) | 21.80% |
| Quarterly Earnings Growth (YOY) | 400.00% |
| Total Debt/Equity (MRQ) | 55.52% |
| Current Ratio (MRQ) | 2.73 |
| Operating Cash Flow (TTM) | 2.83 M |
| Levered Free Cash Flow (TTM) | -1.38 M |
| Return on Assets (TTM) | 12.73% |
| Return on Equity (TTM) | 28.29% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Bullish | Mixed | |
| Stock | Pro-Dex, Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | 0.0 |
| Price Volatility | -0.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -0.5 |
| Average | -0.88 |
|
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Growth |
| % Held by Insiders | 35.95% |
| % Held by Institutions | 29.98% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| CHARLTON ALISHA | 62.74 | 62.74 | 6,903 | 433,094 |
| DOMINGO ANGELITA REBAMONTAN | 62.74 | 62.74 | 4,312 | 270,535 |
| VAN KIRK RICHARD LEE JR | 62.74 | 62.74 | 9,521 | 597,348 |
| Aggregate Net Quantity | 20,736 | |||
| Aggregate Net Value ($) | 1,300,977 | |||
| Aggregate Avg. Buy ($) | 62.74 | |||
| Aggregate Avg. Sell ($) | 62.74 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| DOMINGO ANGELITA REBAMONTAN | Director | 01 Jul 2026 | Acquired (+) | 6,800 | 62.74 | 426,632 |
| DOMINGO ANGELITA REBAMONTAN | Director | 01 Jul 2026 | Disposed (-) | 2,488 | 62.74 | 156,097 |
| VAN KIRK RICHARD LEE JR | Officer | 01 Jul 2026 | Acquired (+) | 14,800 | 62.74 | 928,552 |
| VAN KIRK RICHARD LEE JR | Officer | 01 Jul 2026 | Disposed (-) | 5,279 | 62.74 | 331,204 |
| CHARLTON ALISHA | Officer | 01 Jul 2026 | Acquired (+) | 10,800 | 62.74 | 677,592 |
| CHARLTON ALISHA | Officer | 01 Jul 2026 | Disposed (-) | 3,897 | 62.74 | 244,498 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |